Tonix Pharmaceuticals Holding
NASDAQ: TNXPNew York, US · Founded 2008 · Nevada corporation · 181 employees on LinkedIn
Tonix is a biotechnology company developing therapies for chronic and complex conditions across central nervous system disorders, infectious diseases, immunology/immuno-oncology, and rare diseases. Its pipeline includes candidates for acute stress disorder, PTSD, smallpox/mpox vaccination, organ transplant rejection, and Prader-Willi syndrome.
Founders & leadership
Tonix Pharmaceuticals Holding was founded in 2008 by Seth Lederman.
SL
Seth LedermaninFounder · CEO
GS
Gregory SullivaninChief Medical Officer2014–2026
BS
Bradley SaengerinChief Financial Officer
RR
Rhonda RoseninExecutive
BS
Benjamin SelzerinExecutive
EM
Ernest MarioNamed on SEC filing
SD
Stuart DavidsonNamed on SEC filing
DW
Donald W. LandryNamed on SEC filing
JR
John RhodesNamed on SEC filing
CE
Charles E. Mather IVNamed on SEC filing
MS
Margaret Smith BellNamed on SEC filing
Board
SS
Samuel SaksBoard director
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2012–2017
▶$314.8KraisedOct 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$314.8KraisedOct 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ernest MarioDirector
- Gregory SullivanExecutive Officer
- Bradley SaengerExecutive Officer
- Stuart DavidsonDirector
- Donald W. LandryDirector
- Seth LedermanExecutive Officer, Director
- John RhodesDirector
- Charles E. Mather IVDirector
- Samuel SaksDirector
- Margaret Smith BellDirector
- Patrick GraceDirector
- Offering amount
- $15.3M
- Amount sold
- $314.8K
- First sale
- Sep 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$4.3MraisedJan 2012 · 81 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedJan 2012 · 81 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Patrick GraceDirector
- Charles MatherDirector
- Rhonda RosenExecutive Officer
- John RhodesDirector
- Stuart DavidsonDirector
- Benjamin SelzerExecutive Officer
- Ernest MarioDirector
- Donald LandryDirector
- Seth LedermanExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $4.3M
- Minimum investment
- $10K
- Sales commissions
- $188.2K
- Placement agents
- DAWSON JAMES SECURITIES, INC
- First sale
- Jan 2012
- Incorporated
- Corporation, Nevada, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Robinhood112 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha104 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Tonix Pharmaceuticals Holding for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in Cantor 2026 Global Healthcare Conference - InvestorWire (IW)investorwire.com · Sep 2026Frequently asked questions
- What does Tonix Pharmaceuticals Holding do?
- Tonix is a biotechnology company developing therapies for chronic and complex conditions across central nervous system disorders, infectious diseases, immunology/immuno-oncology, and rare diseases. Its pipeline includes candidates for acute stress disorder, PTSD, smallpox/mpox vaccination, organ transplant rejection, and Prader-Willi syndrome.
- Who founded Tonix Pharmaceuticals Holding?
- Tonix Pharmaceuticals Holding was founded by Seth Lederman in 2008.
- How much funding has Tonix Pharmaceuticals Holding raised?
- Tonix Pharmaceuticals Holding has disclosed $4.6M raised across 2 rounds.
- Where is Tonix Pharmaceuticals Holding headquartered?
- Tonix Pharmaceuticals Holding is headquartered in New York, US.